Skip to product information
1 of 1
Sold Out

Spinal Cord Injury

Spinal Cord Injury

Hardback

Regular price £56.33
Regular price Sale price £56.33

Join our rewards scheme and earn 168 reward points on this purchase!

Earn 168 points on this!

Sign in or Sign up!
View full details
  • Release Date: 27/08/2005
  • Barcode: 9780309095853
  • Genre: Medicine
  • Label: National Academies Press
  • Publisher: National Academies Press
Spinal Cord Injury

Spinal Cord Injury

Collapsible content

DESCRIPTION

Progress, Promise, and Priorities. Nearly 11,000 spinal cord injuries occur each year in the US and more than 200,000 Americans suffer from maladies associated with spinal cord injury. The challenge of restoring function in the wake of these injuries remains complex. This book examines the directions for research aimed at accelerating the development of cures for these injuries.

An estimated 11,000 spinal cord injuries occur each year in the United States and more than 200,000 Americans suffer from maladies associated with spinal cord injury. This includes paralysis, bowel and bladder dysfunction, sexual dysfunction, respiratory impairment, temperature regulation problems, and chronic pain. During the last two decades, longstanding beliefs about the inability of the adult central nervous system to heal itself have been eroded by the flood of new information from research in the neurosciences and related fields. However, there are still no cures and the challenge of restoring function in the wake of spinal cord injuries remains extremely complex.

Spinal Cord Injury examines the future directions for research with the goal to accelerate the development of cures for spinal cord injuries. While many of the recommendations are framed within the context of the specific needs articulated by the New York Spinal Cord Injury Research Board, the Institute of Medicine's panel of experts looked very broadly at research priorities relating to future directions for the field in general and make recommendations to strengthen and coordinate the existing infrastructure. Funders at federal and state agencies, academic organizations, pharmaceutical and device companies, and non-profit organizations will all find this book to be an essential resource as they examine their opportunities.

Table of Contents
  • Front Matter
  • Executive Summary
  • 1 Introduction
  • 2 Progression of Spinal Cord Injury
  • 3 Tools for Assessing Spinal Cord Injury and Repair
  • 4 Current Therapeutic Interventions
  • 5 Progress Toward Neuronal Repair and Regeneration
  • 6 Developing New Therapeutic Interventions: From the Laboratory tothe Clinic
  • 7 Research Organization: Creating an Environment to AccelerateProgress
  • 8 State Programs in Spinal Cord Injury
  • Appendix A Study Process
  • Appendix B Acronyms
  • Appendix C Glossary of Major Terms
  • Appendix D Tools to Assess Spinal Cord Injury Outcomes
  • Appendix E Clinical Trials of Methylprednisolone
  • Appendix F Examples of Alternative Therapies
  • Appendix G Spinal Cord Injury Clinical Trials Published from 1998to 2003
  • Appendix H Legislation Sponsoring State Spinal Cord Injury Research
  • Appendix I Committee and Staff Biographies
  • Index

ADDITIONAL DETAILS

  • Pages: 360
  • DELIVERY & RETURNS

    UK Delivery:

    • Free delivery on all orders of £10 or more.
    • £1.49 delivery fee on orders below £10.
    • UK orders are shipped via Royal Mail 2nd Class.

    International Delivery:

    • Flat rate delivery charges vary by country.

    Dispatch and Delivery Times:

    • All orders are shipped from our warehouse in Northampton, UK within 48 hours of receipt during working hours.
    • UK mainland orders typically arrive within 3-5 working days via Royal Mail 2nd Class.
    • International estimated delivery times:
    • Europe & Channel Islands: 7 to 10 working days
    • USA: 7 to 15 working days
    • Rest of the World: 9 to 21 working days

    View our full delivery infomation here.

    • OVER

      2 MILLION PRODUCTS

    • 60 MILLION CUSTOMERS

      ACROSS 190 COUNTRIES